Skip to content

Inspection of the effectiveness of expiratory muscle training for healthy middle-aged adults

Inspection of the effectiveness of expiratory muscle training for healthy middle-aged adults - Inspection of the effectiveness of expiratory muscle training for healthy middle-aged adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039000
Enrollment
17
Registered
2019-12-25
Start date
2019-12-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Subjects of the intervention group will perform expiratory muscle training and inspiratory muscle training for 7 days a week for 2 weeks.Expiratory muscle training is performed twice a day at 75% of P

Sponsors

Nagasaki University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Person who conducted research explanation and obtained written consent for exercise

Exclusion criteria

Exclusion criteria: 1) In the case where the attending physician decides that it is inappropriate 2) Cases where 8week intervention is impossible 3) Cases scheduled for surgery within the study period 4) Cases with a history of pneumothorax 5) Cases that have developed cancer 6) Cases that have developed asthma

Design outcomes

Primary

MeasureTime frame
maximum expiratory mouth pressure(PEmax)

Secondary

MeasureTime frame
vital capacity(VC), forced vital capacity(FVC), Foced expiratory volume in 1 second(FEV1), FEV1/FVC, maximum inspiratory mouth pressure(PImax), cough peak flow(CPF), Training status, Safety(blood pressure, changes in subjective symptoms)

Countries

Japan

Contacts

Public Contactryo kozu

Nagasaki University Graduate School of Biomedical Sciences Department of Physical Therapy Science

ryokozu@nagasaki-u.ac.jp095-819-7963

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026